1. “Ectopic Pregnancy after Tubal Sterilization”
Jones I.T. Med. J. Aust 1:279-280, 1983
2. “Clinical Trial of Prophylaxis of Wound Sepsis in Elective Colorectal Surgery”
University of Melbourne Colorectal Group Med. J. Aust 2:440-443, 1983
3. “Experience with Percutaneous Transhepatic Biliary Drainage”
Doyle T. & Jones I.T. Aust N.Z. J. Surg 54:461, 1984
4. “A Method That Preserves Continence and Function”
Jones I. T. & Fazio V. W.: Consultant, 26:3,145-157,1986
5. “Desmoid Tumours in Familial Polyposis Coli”
Jones I. T, Jagelman D, Fazio V, Lavery I, Weakley F & McGannon E:
Annals of Surgery 204:94-97; 1986
6. “Rectourethral Fistulas in Crohn’s Disease”
Fazio V, Jones I, Jagelman D & Weakley F.:
Surgery, Gynaecology & Obstetrics 164:148-150; 1987
7. “The Use of Transanal Rectal Advancement Flaps in the Management of Fistulas
Involving the Anorectum.”
Jones I. T., Fazio V. W. & Jagelman D. G.: Dis Colon Rectum 31:50-53; 1988
8. “Definitive Management of Rectal Cancer By Contact (Endocavitary) Irradiation”
Lavery I. C., Jones I. T., Weakley F. L., Sexton J. P., Fazio V. W. & Jagelman D. G.:
Dis Colon Rectum 30:835-838; 1988
9. “The Aetiology and Management of Intestinal Volvulus”
Jones I. T. & Fazio V. W.: Dig Dis 7:203-209; 1989
10. “Best Practice Parameters for Management of Rectal Cancer: Recommendations of the
Colorectal Surgical Society of Australia”
Chapuis P. H., Killingback M. J., Jones, I. T. et al. Aust. N.Z. J. Surg. 66:508-514; 1996
11. “Anorectal Advancement Flap Repair”
Jones I. T. Aust. N.Z. J. Surg. 67 Suppl. 1:A20; 1997
12. “Training in Colonoscopy”
Jones I.T. Aust. N. Z. J. Surg. 68:316-317; 1998
13. “The Use of Prophylactic Ureteric Catheters in Complex Colorectal Surgery”
Dowling C, Jones IT, O’Connell H. Dis Colon Rectum. 42:A19; 1999
14. “Practice Parameters for the Management of Colonic Cancer ”
Surgical Issues. Moore J, Hewett P, Jones IT et al. Aust. N. Z. J. Surg 69:415-421; 1999
15. “Practice Parameters for the Management of Colonic Cancer II”
Adams W, Cartmill J, Jones I. T. et al. Aust NSJ Surg 69:472-78; 1999
16. “Profuse FAP with an APC Exon 3 Mutation”
Nasioulas S, Jones IT, St John J et al
Familial Cancer – 1:3-7; 2001
17. “Appendicovesical fistula”
Steel M, Jones I.T., Webb D
Aust. N.Z. J. Surg. 71:769-771; 2001
18. “Colon Trauma; Royal Melbourne Hospital Experience”
Steel M, Danne P, Jones I.T, Aust. N.Z. J. Surg. 72:357-359; 2002
19. “Open Access Endoscopy”
Jones. I.T. Aust. N.Z.J. Surg. 72:687; 2002
20. “Perianal Fistulae”
Jones I.T. When Not to Cut. Aust. N.Z. Continence Journal 9:52-55; 2003
21. “Small Bowel Malignancy: An Elusive Diagnosis”
Chandra R, Miller J, Jones Ian T et al Med J Aust 180: 182-183; 2004
22. “Evidence Supports Adjuvant Therapy in Selected Patients with Rectal Cancer”
Gibbs P, Chao M, Jones IT, Yip D, Aust. N.Z. J. Surg: 74:152-157; 2004
23. “Carcinoma of the Anal Canal: A Local Experience”
Wong S, Gibbs P, Jones IT, et al Aust. N. Z. J. Surg 74:541-546; 2004
24. Evaluation of The Use of Computed Tomography Versus Conventional Orthogonal X-ray Simulation In The Treatment of Rectal Cancer”
Chao M, Gibbs P, Jones IT et al. Aust Radiol 49:122-126; 2005
25. “Preoperative Chemotherapy and Radiotherapy for Locally Advanced Rectal Cancer”
Chao M, Gibbs P, Jones IT et al, Aust NZ J Surg 75: 286-291; 2005
26. “Clinical Spectrum of Crohn’s Disease in a Single Surgeon’s Experience
Leung R., Jones I.T., Aust N.Z.J. Surg 75:471-474; 2005
27. Sub-site specific Colorectal Cancer in Diabetic and Non-diabetic Patients
Lim E, Jones IT, Gibbs P et al. Cancer Epidemiol Biomarkers Prev 14:1579-1582; 2005
28. More Evidence of the Benefits of Case Volume and Specialisation in Colorectal Surgery
Jones I. T., Aust NZ J Surg 75:839; 2005
29. Completion of Therapy by Medicare Patients with Stage III Colon Cancer
Gibbs P, McLaughlin S, Skinner I, Jones I et al. J Natl Cancer Inst 98:1582; 2006
30. Managing an Emerging Trauma Epidemic in Australia
Rozen WM, Ma EH, Jones IT, Judson RT. Aust NZ J Surg 77(S1):A95-96; 2007
31. Type 2 Diabetes Mellitus, Smoking and Colorectal Cancer
Gibbs P, Steel S, Jones IT et al. Am J Gastro 102:909-910; 2007
32. Writing to the Next of Kin after the Death of a Patient
Jones IT. Med J Aust 187: 200, 2007
33. An Emerging Epidemic in Australia: Abdominal Stab Wounds
Rozen WM, Ma EH, Jones IT, Judson RT. Emerg Med Australas 2007; 19:262-268
34. Comparing Survival Outcomes For Patients With Colorectal Cancer
Kosmider S, Jones IT, Hayes IP, Gibbs P. Med J Aust 2007; 187: 250-251
35. Long Term Outcomes of Patients With Localised Rectal Cancer Treated with Chemoradiotherapy or Radiotherapy Alone
Lim L, Chao M, Jones IT et al. Dis Colon Rectum 2007; 50:2032-2039
36. Value Of Database Linkage: Are Patients At Risk Of Familial Colorectal Cancer Being Referred For Genetic Counseling And Testing
Wong C, Gibbs P, Jones IT et al. Intern Med J 2008; 38:328-333
37. A Critical Review Of The Glasgow Prognostic Score For Colorectal Cancer.
Shedda S, Kosmides S, Faragher I, Jones I, Gibbs P. Ann Surg 2008; 247:1087-88
38. Towards Establishing A National Colorecal Cancer Database.
Kosmider S, Jones I, Hibbert M et al. ANZJ Surg 2008; 78:803-809
39. Residual Treatment Disparities After Oncology Referral For Rectal Cancer
Field K M, Kosmider S, Desai J, Jones I T et al. J Natl Cancer Inst 2008; 100:1739
40. Guidelines For The Management Of Haemodynamically Stable Patients With Stab Wounds To The Anterior Abdomen
Rosen W M, Jones I T, Judson R T. ANZ J Surg 2008; 78:105-106
41. DNA Copy-number Alterations Underlie Gene Expression Differences Between Microsatellite Stable And Unstable Colorectal Cancers
Jorissen RN, Lipton L, Gibbs P, Jones IT et al. Clin Cancer Res 2008 Dec 15; 14(24):8061-9
42. Patient Age And Comorbidity Are Major Determinants Of Adjuvant Chemotherapy Use For Stage III Colon Cancer In Routine Clinical Practice
Ananda S, Dosmider S, Jones IT et al. J Clin Oncol 2008 Sept 20; 26(27):4516-7
43. APER Rate Has Multiple Limitations As An Indicator Of Quality In Rectal Cancer Surgery
Shedda S, Croxford M, Jones I, Gibbs P. Ann Surg 2008 Dec 248 (6):1105
44. Initial Impact Of Australia’s National Bowel Cancer Screening Program
Ananda S, Shedda S, McLaughlin SJ, Jones IT et al. Med J Aust 2009 Oct 5; 191(7):378-81
45. Predictors Of Clinic Non-Attendance – Opportunities To Improve Patient Outcomes In Colorectal Cancer
Kosmider S, Shedda S, Jones I, McLaughlin S, Gibbs P. Intern Med J 2010; 40:757-63
46. Surveillance Of FAP: A Prospective Blinded Comparison Of Capsule Endoscopy And Other GI Imaging To Detect Small Bowel Polyps
Tescher P, Macrae F, Jones IT et al. Hered Cancer Clin Pract 2010; 8:3
47. Lymph Node Yield Following Colorectal Cancer Surgery in Australia
Field K, Platell C, Jones IT et al. ANZ J Surg 2011 Apr; 81(4): 266-71
48. Optimizing Targeted Therapeutic Development: Analysis of A Colorectal Cancer Patient Population With The BRAF Mutation
Tie J, Gibbs P, Jones IT et al. International Journal of Cancer 2011 May 1; 128(9): 2075-84
49. Preliminary Analysis of The Cost-Effectiveness Of The National Bowel Cancer Screening Program – Analysing The Impact Of Rising Colorectal Cancer Treatment Costs
Tran B, Ananda S, Jones IT et al. Intern Med J 2012; 42:794-800
50. SMAD2, SMAD3, SMAD4 Mutations in Colorectal Cancer
Fleming N, Jones I, Gibbs P, Sieber O et al. Cancer Research 2012 November 8
51. Brachial Plexopathy in Laparoscopic Assisted Rectal Surgery
Eteuati J, Hiscock R, Jones IT et al. Tech Coloproctol Nov 28 2012
52. Different APC Genotypes in Proximal and Distal Sporadic Colorectal Cancer Suggest Distinct WNT/Beta Catenin Signaling thresholds for Tumourigenesis.
Christie M, Jones IT et al. Oncogene (accepted for publication) 2013
53. PIK3CA and PTEN Gene and Exon Mutation – Specific Clinicopathologocial and Molecular Associations in Colorectal Cancer.
Day F, Jorissen R, Lipton L, Jones IT et al. Clinical Cancer Research (accepted for publication) 2013
54. Quality of Life after Surgery in Individuals with Familial Colorectal Cancer: Does extended Surgery have an Adverse Impact.
Pollett WG, Marion K, Jones IT et al. ANZ J Surg 2013; Aug7 10.1111/12336 (epub)
55. Brachial Plexopathy Injury due to Laparoscopic Rectal Surgery.
Eteuati J, Jones IT. Colorectal Dis 2013; 15:1313
56. Second Primary Colorectal Cancer in the Era of Prevalent Screening and Imaging
Bae S, Gibbs P, Jones IT et al. ANZJS 2013; 83:963-7
57. Survival in Stage II/III Colorectal Cancer is Independently Predicted by Chromosomal and Microsatellite Instability, but not by Specific Driver Mutations
Mouradov D, Domingo E, Gibbs P, Jones IT et al. Am J Gastroenterol 2013; 108:1785-93
58. Translation of Clinical Trial Outcomes to Metastatic Colorectal Cancer Patients in Community Practice
Lok SW, Wong HL, Jones I et al. Asia Pac J Clin Oncol 2014 10: 361-367
59. Impact of Regular Aspirin Use On Overall And Cancer-Specific Survival In Patients With Colorectal Cancer Harboring A PIK3CA Mutation
Kothari N, Kim R, Jones I et al. Acta Oncol 2014 Dec 31: 1-16
60. Outcomes in the Surgical Treatment of Low Rectal Cancer: Does Neoadjuvant Treatment Equalize results?
Pollett WG, Gibbs P, McLaughlin S, Jones I et al. ANZ J Surg. 85 (2015) 140-144
61. Comparison of ECOG/WHO Performance Status and ASA Score as a Measure of Functional Status
Young J, Badgery-Parker T, Jones I et al. J Pain Symptom Manage (2015) 49: 258-264
62. Comparing Oncological Outcomes Of Laparoscopic Versus Open Surgery For Colon Cancer: Analysis Of A Large Prospective Clinical Database
Sammour T, Hayes I, Jones I T et al. J Surg Onc. 111 (2015) 891-898
63. Considerations And Management Of A Patient With Three Metachronous Cancers In Association With Lynch Syndrome And Ileal Crohn’s Disease: A Case Report
Lourensz K, Jones I. Int J Case Rep 10 (2015)73-75
64. Impact Of Diabetes Status And Medication On Presentation, Treatment and Outcome Of Stage II Colon Cancer Patients
Bae S, Wong H-L, Tie J, Desai J, Field K, Kosmider S, Fourlanos S, Jones I, Skinner I, Gibbs P. J Can Epid (2015) 1-8.
65. Recurrence in Patients with Stage 1 Colorectal Cancer
Teloken P, Ransom D, Faragher I, Jones I, Gibbs P, Platell C
ANZJ Surg (accepted for publication)
66. A Randomized Controlled Trial of Light Versus Deep Propofol Sedation for Elective Outpatient Colonoscopy
Allen M, Leslie K, Hebbard G, Jones I et al.
Can J Anesth (2015) 62:1169-1178
67. Analysis of Local Chronic Inflammatory Cell Infilltrate Combined with Systemic Inflammation Improves Prognostication in Stage II Colon Cancer Independent of Standard Clinicopathologic Criteria
Turner N, Wong HL, Templeton A, Jones I et al. Int J Cancer (2015) (epub)
68. Triradiate Caecal Fold: Is it a Useful Landmark for Caecal Intubation in Colonoscopy?
Finlayson A, Chandra R, Jones IT et al. World J Gastro Endosc (2015) 7:1103-1106
69. Primary Tumour Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal Of Systemic Inflammation and Improved Survival.
Turner N, Tran B, Jones I et al
Clin Colorectal Cancer 2015 Sep;14(3): 185-91
70. Primary Tumour Resection and Overall Survival in Patients with Metastatic Colorectal Cancer Treated with Palliative Intent
Wong SF, Wong HL, Field KM, Jones IT et al
Clin Colorectal Cancer 2015 Dec 29 s1533-0028 (15) 00161-9 (Epub)
71. Survival Impact of the Australian National Bowel Cancer Screening Programme
Ananda S, Wong H, Jones IT et al
Intern Med J 2016, 46: 166-171
72. Total Caseload of a Colorectal Surgical Unit: Baseline Measurement and Identification of Areas for Efficiency Gains
Sammour T, Macleod A, Jones IT et al
Int J Colorectal Dis 2016 DOI 10.1007/s00384-016-2556-z
73. The Rapidly Escalating Cost of Treating Colorectal Cancer in Australia
Ananda S, Kosmider S, Jones IT et al
Asia Pac J Clin Oncol 2016, 12: 33-40
74. Telomere Lengths in Tumour and Normal Mucosa are Related to Disease Progression and Chromosome Instability Profiles in Colorectal Cancer
Suraweera N, Mourador D, Shan L, Jones IT et al
Oncotarget 2016 (Accepted for Publication)